K65R突变患者使用AZT还是替诺福韦?

Jonathan Z. Li, P. Sax
{"title":"K65R突变患者使用AZT还是替诺福韦?","authors":"Jonathan Z. Li, P. Sax","doi":"10.1056/AC201005030000002","DOIUrl":null,"url":null,"abstract":"The K65R mutation in HIV confers a three- to four-fold decrease in phenotypic susceptibility to the nucleoside reverse transcriptase inhibitor (NRTI)","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"92 1","pages":"51-2"},"PeriodicalIF":0.0000,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"AZT or tenofovir for patients with the K65R mutation?\",\"authors\":\"Jonathan Z. Li, P. Sax\",\"doi\":\"10.1056/AC201005030000002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The K65R mutation in HIV confers a three- to four-fold decrease in phenotypic susceptibility to the nucleoside reverse transcriptase inhibitor (NRTI)\",\"PeriodicalId\":88277,\"journal\":{\"name\":\"Journal watch. AIDS clinical care\",\"volume\":\"92 1\",\"pages\":\"51-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal watch. AIDS clinical care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1056/AC201005030000002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal watch. AIDS clinical care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1056/AC201005030000002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

HIV中的K65R突变使对核苷逆转录酶抑制剂(NRTI)的表型易感性降低三到四倍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
AZT or tenofovir for patients with the K65R mutation?
The K65R mutation in HIV confers a three- to four-fold decrease in phenotypic susceptibility to the nucleoside reverse transcriptase inhibitor (NRTI)
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信